RECEPTAGEN CORP has a total of 21 patent applications. Its first patent ever was published in 1993. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are CHO HO SUNG, BIO BLAST PHARMA LTD and INNATE PHARMA SAS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Australia | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Canada | 2 | |
#6 | New Zealand | 2 | |
#7 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Macromolecular chemistry and polymers | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Sugars | |
#4 | Peptides | |
#5 | Unspecified technologies | |
#6 | Macromolecular compounds compositions | |
#7 | Special macromolecular compounds |
# | Name | Total Patents |
---|---|---|
#1 | Wilbur D Scott | 12 |
#2 | Morgan A Charles Jr | 11 |
#3 | Pathare Pradip M | 9 |
#4 | Morgan A Charles | 4 |
#5 | Quadros Edward V | 3 |
#6 | Rothenberg Sheldon P | 3 |
#7 | Morgan Alton Charles | 2 |
#8 | Morgan Jr Alton Charles | 2 |
#9 | Morgan Alton Charles Jr | 2 |
#10 | Pathare M Pradip | 1 |
Publication | Filing date | Title |
---|---|---|
US2003064066A1 | Anti-receptor and growth blocking agents to the vitamin B12/transcobalamin II receptor and binding sites | |
AU7164700A | Vitamin B12 receptor modulating agents and methods related thereto | |
EP1015475A1 | Vitamin b 12? receptor modulating agents and methods related thereto | |
AU3683395A | Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites | |
CA2187346A1 | Receptor modulating agents and methods relating thereto | |
US5869465A | Methods of receptor modulation and uses therefor | |
US5840880A | Receptor modulating agents | |
NZ252559A | Antibodies or derivatives thereof to vitamin b12/transcobalamin ii receptor and use in preventing cellular uptake of vitamin b12 and inhibiting cell division |